Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells

World Journal of Gastroenterology

Volumn 11, Issue 21, 2005, Pages 3204-3211

  Zheng, Shi Ying ^a   Li, De Chun ^a   Zhang, Zhi De ^a   Zhao, Jun ^a   Ge, Jin Feng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

B7 1 gene; FasL gene; Gastric cancer; Gene therapy; Synergistic effect

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CLONE; CONTROLLED STUDY; DNA MODIFICATION; DNA STRUCTURE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOSTIMULATION; INOCULATION; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOTOXICITY; MOUSE; NONHUMAN; PROVOCATION TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; SPLEEN CELL; STOMACH CANCER; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNITY; WILD TYPE;

EID: 22144499199     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i21.3204     Document Type: Article

References (34)

1. Grosenbach DW, Schlom J, Gritz L, Yafal AG, Hodgea JW. A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production. Cellular Immunol 2003; 222: 45-57
2. Khatlani TS, Ma Z, Okuda M, Onishi T. Molecular cloning and sequencing of canine T-cell costimulatory molecule (CD28). Vet Immunol Mmunopathol 2001; 78: 341-348
3. Shankar P, Schlom J, Hodgeb JW, Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3). Vaccine 2002; 20: 744-755
4. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schopf E, Simon JC. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Int J Cancer 1995; 62: 259-265
5. Nagai A, Nakagawa E, Hatori K, Choi HB, McLarnon JG, Lee MA, Kim SU. Generation and characterization of immortalized human microglial cell lines: Expression of cytokines and chemokines. Neurobiol Dis 2001; 8: 1057-1068
6. Sharma K, Wang RX, Zhang DL, Yin DL, Luo XY, Solomon JC, Jing RF, Markos K, Davidson W, Scott DW, Shi YF. Death the Fas way: regulation and pathophysiology of CD95 the its ligand. Pharmacol Ther 2000; 88: 333-347
7. Rad AN, Schlom J, Hodge JW. Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursors. Critical Rev Oncol Hematol 2001; 39: 43-57
8. Shering AF, Bain D, Stewart K, Epstein AL, Castro MG, Wilkinson GW, Lowenstein PR. Celltype-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors. J Gen Virol 1997; 78(Pt 2): 445-459
9. Buggins AG, Lea N, Gaken J, Darling D, Farzaneh F, Mufti GJ, Hirst WJ. Effect of costimulation and the microenvironment on antigen presentation by leukemic cells. Blood 1999; 94: 3479-3490
10. Qiu ZH, Wu CT, Lao MF, Pan LZ, Li YM. Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte macrophage colony-stimulating factor and B7-1 genes. Cancer Lett 2002; 182: 147-154
11. McCarthya DO, Meisnera LF, Bourdeau-Hellera J, Robertsa TR, Wub SQ, Warnera TF, Albertinia MR. Localization of transfected B7-1 (CD80) DNA in human melanoma cells after particle-mediated gene transfer. Cancer Genet Cytogenet 2003; 144: 106-111
12. Zheng J, Si LS, Song JM, Sun XL, Yu J, Wang Y. Enhanced immune response to DNA-based HPV16L1 vaccination by costimulatory molecule B7-2. Antiviral Res 2003; 59: 61-65
13. Seko Y, Takahashi N, Tada Y, Yagita H, Okumura K, Nagai R. Restricted usage of T-cell receptor Vγ-Vδ genes and expression of costimulatory molecules in Takayasu's arteritis. Int J Cardiol 2000; 75(Suppl 1): S77-S83
14. Fox SA, Loh S, Thean AL, Garlepp MJ. Identification of differentially expressed genes in murine mesothelioma cell lines of differing tumorigenicity using suppression subtractive hybridization. Biochim Biophys Act 2004; 1688: 237-244
15. Fujii K, Inobe M, Kimura F, Murata J, Murakami M, Onisih Y, Azuma I, Uede T, Saiki I. Vaccination of tumor cells transfected with the B7-1(CD80) gene induces the anti-metastatic effect and tumor immunity in mice. Int J Cancer 1996; 66: 219-224
16. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1456
17. Webb SD, Sherratt JA, Fish RG. Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology. Math Biosci 2002; 179: 113-129
18. Houston A, O'Connell J. The Fas signaling pathway and its role in the pathogenesis of cancer. Curr Opin Pharmacol 2004; 4: 321-326
19. Lee SH, Bar-Haim E, Goldberger O, Reich-Zeliger S, Vadai E, Tzehoval E, Eisenbach L. Expression of FasL by tumor cells does not abrogate anti-tumor CTL function. Immunol Lett 2004; 91: 119-126
20. Toillon RA, Descamps S, Adriaenssens E, Ricort JM, Bernard D, Boilly B, Le Bourhis X. Normal breast epithelial cells induce apoptosis of breast cancer cells via fas signaling. Exp Cell Res 2002; 275: 31-43
21. Arai H, Gordon D, Nabel EG, Nabel GJ. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci USA 1997; 94: 13862-13867
22. Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178
23. Kawasaki M, Kuwano K, Nakanishi Y, Hagimoto N, Takayama K, Pei XH, Maeyama T, Yoshimi M, Hara N. Analysis of Fas and Fas ligand expression and function in lung cancer cell lines. Eur J Cancer 2000; 36: 656-663
24. Nafe C, Cao YJ, Quinones A, Dobberstein KU, Kramm CM, Rainov NG. Expression of mutant non-cleavable Fas ligand on retrovirus packaging cells causes apoptosis of immunocompetent cells and improves prodrug activation gene therapy in a malignant glioma model. Life Sci 2003; 73: 1847-1860
25. Lang S, Atarashi Y, Nishioka Y, Stanson J, Meidenbauer N, Whiteside TL. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death. Cell Immunol 2000; 201: 132-143
26. Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K, Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 2001; 97: 1809-1816
27. Arlena PM, Gulleya JL, Palenaa C, Marshallb J, Schloma J, Tsanga KY. A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen presenting cells expressing vector-driven human B7-1. J Immunol Methods 2003; 279: 183-192
28. Tan LJ, Jing N, Zhang N, Zhang XR, Qiu DH. Fas/FasL expression of esophageal squamous cell cancinoma, dysplasia tissues and normal mucosa. Shijie Huaren Xiaohua Zazhi 2001; 9: 15-19
29. Reichmann E. The biological role of the Fas/FasL system during tumor formation and progression. Semin Cancer Biol 2002; 12: 309-315
30. Shinoura N, Muramatsu Y, Yoshida Y, Asai A, Kirino T, Hamada H. Adenovirus-mediated transfer of caspase-3 with Fas ligand induces drastic apoptosis in U-373MG glioma cells. Exp Cell Res 2000; 236: 423-433
31. Ganss R, Hanahan D. Tumor microenviroment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Res 1998; 58: 4673-4681
32. McCarthya DO, Meisnera LF, Bourdeaul-Hellera J, Robertsa TR, Wub SQ, Warnera TF, Albertinia MR. Localization of transfected. B7-1 (CD80) DNA in human melanoma cells after particle mediated gene transfer. Cancer Genet Cytogenet 2003; 144: 106-111
33. Salford LG, Siesjo P, Skagerberg G, Persson BRR, Larsson EM, Lindvall M, Visse E, Widegren B. Search for effective therapy against glioblastoma multiforme-clinical immunization with autologous glioma cells transduced with the human interferon-γ gene. International Congress Series 2002; 1247: 211-220
34. Tao G, Hu J, Zou H, Lin Q, Liu F, Wu Y, Sun Q. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene. Chin Med J 2001; 114: 623-627